News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
394,927 Results
Type
Article (26456)
Company Profile (60)
Press Release (368409)
Multimedia
Podcasts (34)
Webinars (7)
Section
Business (104591)
Career Advice (455)
Deals (16931)
Drug Delivery (53)
Drug Development (47831)
Employer Resources (47)
FDA (12368)
Job Trends (8504)
News (186709)
Policy (19545)
Tag
2027 Biotech Bay Standard (1)
2027 Pharm Country Standard (1)
Academia (1769)
Accelerated approval (14)
Adcomms (10)
Allergies (110)
Alliances (26909)
ALS (95)
Alzheimer's disease (972)
Antibody-drug conjugate (ADC) (161)
Approvals (12702)
Artificial intelligence (302)
Autoimmune disease (89)
Automation (8)
Bankruptcy (142)
Best Places to Work (6911)
BIOSECURE Act (5)
Biosimilars (73)
Biotechnology (40)
Bladder cancer (124)
Brain cancer (36)
Breast cancer (414)
Cancer (3073)
Cardiovascular disease (265)
Career advice (416)
Career pathing (15)
CAR-T (133)
CDC (26)
Celiac Disease (2)
Cell therapy (363)
Cervical cancer (26)
Clinical research (43026)
Collaboration (852)
Compensation (278)
Complete response letters (16)
COVID-19 (1560)
CRISPR (35)
C-suite (484)
Cystic fibrosis (59)
Data (4231)
Decentralized trials (2)
Denatured (20)
Depression (93)
Diabetes (316)
Diagnostics (3716)
Digital health (28)
Diversity (7)
Diversity, equity & inclusion (13)
Drug discovery (94)
Drug pricing (91)
Drug shortages (22)
Duchenne muscular dystrophy (123)
Earnings (38690)
Editorial (28)
Employer branding (6)
Employer resources (46)
Events (54282)
Executive appointments (585)
FDA (14648)
Fibrodysplasia Ossificans Progressiva (2)
Friedreich's ataxia (5)
Frontotemporal dementia (10)
Funding (752)
Gene editing (75)
Generative AI (20)
Gene therapy (258)
GLP-1 (544)
Government (3148)
Grass and pollen (4)
Guidances (229)
Healthcare (12243)
HIV (38)
Huntington's disease (20)
IgA nephropathy (50)
Immunology and inflammation (81)
Immuno-oncology (25)
Indications (67)
Infectious disease (1693)
Inflammatory bowel disease (109)
Inflation Reduction Act (7)
Influenza (52)
Intellectual property (118)
Interviews (40)
IPO (7098)
IRA (23)
Job creations (1848)
Job search strategy (381)
JPM (18)
Kidney cancer (10)
Labor market (34)
Layoffs (196)
Leadership (8)
Legal (3647)
Liver cancer (67)
Longevity (7)
Lung cancer (488)
Lymphoma (249)
Machine learning (16)
Management (17)
Manufacturing (290)
MASH (105)
Medical device (13305)
Medtech (13350)
Mergers & acquisitions (10351)
Metabolic disorders (750)
Multiple sclerosis (96)
NASH (11)
Neurodegenerative disease (160)
Neuropsychiatric disorders (42)
Neuroscience (1687)
NextGen: Class of 2026 (3945)
Non-profit (2839)
Now hiring (33)
Obesity (310)
Opinion (95)
Ovarian cancer (119)
Pain (140)
Pancreatic cancer (140)
Parkinson's disease (164)
Partnered (17)
Patents (227)
Patient recruitment (351)
Peanut (42)
People (35683)
Pharmaceutical (15)
Pharmacy benefit managers (16)
Phase 1 (12370)
Phase 2 (18624)
Phase 3 (15276)
Pipeline (3032)
Policy (125)
Postmarket research (1670)
Preclinical (3812)
Press Release (18)
Prostate cancer (177)
Psychedelics (26)
Radiopharmaceuticals (177)
Rare diseases (425)
Real estate (2878)
Recruiting (18)
Regulatory (15704)
Reports (18)
Research institute (1659)
Resumes & cover letters (49)
Rett syndrome (16)
RNA editing (5)
RSV (39)
Schizophrenia (113)
Series A (117)
Series B (94)
Service/supplier (2)
Sickle cell disease (45)
Special edition (6)
Spinal muscular atrophy (104)
Sponsored (16)
Startups (2138)
Stomach cancer (11)
Supply chain (60)
Tariffs (25)
The Weekly (14)
Vaccines (506)
Venture capital (27)
Weight loss (209)
Women's health (54)
Worklife (4)
Date
Today (4)
Last 7 days (303)
Last 30 days (1160)
Last 365 days (16231)
2026 (1477)
2025 (16551)
2024 (19897)
2023 (22785)
2022 (30759)
2021 (33073)
2020 (32278)
2019 (28475)
2018 (21865)
2017 (18961)
2016 (18174)
2015 (21282)
2014 (16098)
2013 (13299)
2012 (14392)
2011 (14676)
2010 (13228)
Location
Africa (368)
Alabama (30)
Alaska (2)
Arizona (174)
Arkansas (10)
Asia (25542)
Australia (4039)
California (5578)
Canada (1915)
China (782)
Colorado (285)
Connecticut (284)
Delaware (249)
Europe (50047)
Florida (970)
Georgia (228)
Hawaii (1)
Idaho (35)
Illinois (596)
India (32)
Indiana (376)
Iowa (11)
Japan (314)
Kansas (90)
Kentucky (19)
Louisiana (18)
Maine (28)
Maryland (890)
Massachusetts (3745)
Michigan (149)
Minnesota (442)
Mississippi (5)
Missouri (78)
Montana (19)
Nebraska (21)
Nevada (65)
New Hampshire (73)
New Jersey (1926)
New Mexico (10)
New York (1562)
North Carolina (811)
North Dakota (4)
Northern California (2651)
Ohio (212)
Oklahoma (8)
Oregon (28)
Pennsylvania (1360)
Puerto Rico (11)
Rhode Island (35)
South America (525)
South Carolina (59)
Southern California (2235)
Tennessee (124)
Texas (1017)
United States (21675)
Utah (194)
Virginia (141)
Washington D.C. (52)
Washington State (384)
West Virginia (4)
Wisconsin (71)
Wyoming (1)
394,927 Results for "micron medical".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Tigermed Completes Acquisition of Japanese CRO Micron
July 29, 2025
·
3 min read
Press Releases
Emory University and Micron Biomedical Launch First-in-Human Clinical Trial of Next-Generation Rotavirus Vaccine Delivered via Dissolvable Microarray Technology
June 16, 2025
·
5 min read
Drug Development
Micron Biomedical Announces The Lancet Publication of Positive Phase 1/2 Data From First Clinical Trial of Needle-Free Vaccines in Children
Micron Biomedical, a life science company developing first-in-class dissolvable microarray-based products that simplify and improve the transport, storage, and administration of drugs and vaccines, today announced the publication of its positive Measles and Rubella (MR) Phase 1/2 trial data in The Lancet Medical Journal.
May 1, 2024
·
5 min read
Press Releases
Micron Biomedical Extends Series A Financing to 33+ Million to Accelerate Commercialization of Needle-Free Therapeutics and Vaccines
January 16, 2025
·
4 min read
Press Releases
Exyte Receives Micron’s Outstanding Supplier Performance Award in Supplier Diversity
November 26, 2024
·
2 min read
Business
Micron Biomedical Appoints Global Health Pioneer and Champion of Vaccine Access, Dr. Seth Berkley, as Scientific Advisor to the CEO
Micron Biomedical, a life science company developing first-in-class dissolvable microarray-based products that simplify and improve the transport, storage, and administration of drugs and vaccines, announced the appointment of global public health pioneer, Dr. Seth Berkley, as scientific advisor to the CEO.
February 27, 2024
·
3 min read
Genetown
Micron Solutions, Inc. Board Announces Proposal for Stock Splits
Micron Solutions, Inc., through its wholly-owned subsidiary, Micron Products, Inc. announced the Board’s approval of a proposal to effect a 1-for-1,000 reverse stock split of the Company’s Common Stock, followed immediately by a 1,000 to 1 forward stock split for the Company’s Common Stock, which Stock Splits will be enacted through the filing of amendments to the Company’s Certificate of Incorporation with the Secretary of State of the State of Delaware.
October 2, 2023
·
8 min read
BioMidwest
Micron Biomedical Receives $23.6 Million to Accelerate Commercial Manufacturing of Needle-Free Vaccines and to Help Eradicate Measles
Micron Biomedical announced a $23.6 million grant from the Bill & Melinda Gates Foundation that will fund mass production of needle-free vaccines.
November 16, 2023
·
4 min read
Press Releases
CEPI and Micron Biomedical Accelerate Needle-Free Vaccines against Disease X with $3.7 Million Grant to Advance Learnings from COVID-19
January 9, 2025
·
6 min read
Press Releases
Micron Biomedical Wins $2 Million BARDA Competition for Its Collaboration with Zipcode Bio to Develop mRNA-Based Broad Protecting Flu Vaccine Without Needles
January 14, 2025
·
4 min read
1 of 39,493
Next
